Teva Pharmaceutical reported 1.14B in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aspen Pharmacare APN:SJ 5.04B 497M
Cipla CIPLA:IN IR 13458.9M 5496.5M
Dr.Reddys Laboratories DRRD:IN IR 9183M 1364M
Kalbe Farma Tbk Pt KLBF:IJ RI 1175452.76M 86115.01M
Richter Gedeon RICHT:HB 47.4B 12.5B
Sun Pharmaceuticals SUNP:IN IR 27412M 6819.8M
Teva Pharmaceutical TEVA:IT 1.14B 34M